A new way to guess how much drug reaches a brain tumor
Original title: Combining imaging strategies with physiologically-based pharmacokinetic modeling to improve precision dosing & drug delivery in brain tumors.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a view on where the science should go next, not a new result in people.
The short version
Researchers say brain scans could show how much of a drug actually gets into a tumor.
What was studied. This is a viewpoint paper, not a new study in people. The authors looked at how to tell how much of a drug reaches a brain tumor, instead of just how much is in the blood.
What they found. Targeted pill drugs often fail to control brain tumors. That happens even at doses high enough to cause side effects. The amount in the blood does not match the amount in the tumor. What gets in is set by the blood-brain barrier, the filter that guards the brain. Drugs also do not spread evenly inside a tumor, so some spots barely get any.
What this means, and what it doesn't
What it could mean: Nothing about your care changes today. Over time, this work could help doctors pick drugs and doses that reach the tumor better. It may also show which drugs are not worth trying for brain tumors.
What it doesn't mean: This is not a new drug, and it is not a test you can ask for. No one was treated in this paper. It is an argument about how research should move ahead. It is far from everyday care, and it is not a promise of a cure.
Source: PubMed, October 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.